Hypera Stock

Hypera CapEx/D&A

CapEx to Depreciation Ratio of Hypera (HYPE3.SA) as of Aug 14, 2026.

CapEx/D&A

0.00

Last updated:

CapEx to Depreciation Ratio of Hypera is 2026 0.00 . CapEx to Depreciation Ratio of Hypera was 2025 4.70 . It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API

Hypera Stock analysis

What does Hypera do? Hypera SA is a Brazilian pharmaceutical company founded in 2001, specializing in the development, production, and distribution of drugs, generics, medical devices, and cosmetic products primarily for the Brazilian healthcare industry. Hypera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Hypera stock

On Eulerpool you can find the complete historical development of CapEx to Depreciation Ratio Hypera since 2006 – with annual values, charts, and detailed analysis.

The CapEx/D&A ratio compares investment spending to asset depreciation. Ratios above 1.0x indicate the company is growing its asset base, below 1.0x suggests underinvestment.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Depreciation Ratio's Hypera with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Depreciation Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Depreciation Ratio.

Access this data via the Eulerpool API

Cash Flow — Hypera

All Key Metrics — Hypera